These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34846443)

  • 21. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
    Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered nanomedicine for myeloma and bone microenvironment targeting.
    Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.
    Doolittle E; Peiris PM; Doron G; Goldberg A; Tucci S; Rao S; Shah S; Sylvestre M; Govender P; Turan O; Lee Z; Schiemann WP; Karathanasis E
    ACS Nano; 2015 Aug; 9(8):8012-21. PubMed ID: 26203676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
    Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
    J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl
    Liu X; Xu Y; Yin L; Hou Y; Zhao S
    Int J Nanomedicine; 2021; 16():5675-5692. PubMed ID: 34456564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
    Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
    Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
    Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-dependent changes in phagocytic activity: in vivo response of mouse pulmonary antigen presenting cells to direct lung delivery of charged PEGDA nanoparticles.
    Sudduth ER; López Ruiz A; Trautmann-Rodriguez M; Fromen CA
    J Nanobiotechnology; 2024 Aug; 22(1):476. PubMed ID: 39135064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases.
    Liu Y; Crowe WN; Wang L; Lu Y; Petty WJ; Habib AA; Zhao D
    Nat Commun; 2019 Nov; 10(1):5108. PubMed ID: 31704921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
    Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
    Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating Elasticity of Liposome for Enhanced Cancer Immunotherapy.
    Yuan P; Yan X; Zong X; Li X; Yang C; Chen X; Li Y; Wen Y; Zhu T; Xue W; Dai J
    ACS Nano; 2024 Aug; 18(34):23797-23811. PubMed ID: 39140567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants.
    Valsalakumari R; Pandya AD; Prasmickaite L; Kvalvaag A; Myrann AG; Åslund AKO; Kjos MS; Fontecha-Cuenca C; Haroon HB; Ribeiro ARS; Horejs-Hoeck J; Moghimi SM; Mørch Ý; Skotland T; Sandvig K; Mælandsmo GM; Iversen TG
    Int J Nanomedicine; 2024; 19():3009-3029. PubMed ID: 38562610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multitarget, multiagent PLGA nanoparticles for simultaneous tumor eradication and TME remodeling in a melanoma mouse model.
    Ramzy A; Soliman AH; Hassanein SI; Sebak AA
    Drug Deliv Transl Res; 2024 Feb; 14(2):491-509. PubMed ID: 37612575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response to launch a powerful antitumor adaptive immune response.
    Liang X; Li L; Li X; He T; Gong S; Zhu S; Zhang M; Wu Q; Gong C
    Theranostics; 2021; 11(14):6936-6949. PubMed ID: 34093863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.
    Guo C; Chen Y; Gao W; Chang A; Ye Y; Shen W; Luo Y; Yang S; Sun P; Xiang R; Li N
    Theranostics; 2017; 7(3):775-788. PubMed ID: 28255366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy.
    Masjedi A; Ahmadi A; Ghani S; Malakotikhah F; Nabi Afjadi M; Irandoust M; Karoon Kiani F; Heydarzadeh Asl S; Atyabi F; Hassannia H; Hojjat-Farsangi M; Namdar A; Ghalamfarsa G; Jadidi-Niaragh F
    Nanomedicine; 2020 Oct; 29():102240. PubMed ID: 32553948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of Platycodonis Radix-Curcumae Rhizoma on oral nanoparticle uptake and in vitro inhibition against breast cancer metastasis].
    Shi JP; Zhang RG; Gu XY; Sun YW; Feng NP; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2419-2425. PubMed ID: 37282871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.